OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biphenyl Gal and GalNAc FmlH Lectin Antagonists of Uropathogenic E. coli (UPEC): Optimization through Iterative Rational Drug Design
Amarendar Reddy Maddirala, Roger D. Klein, Jerome S. Pinkner, et al.
Journal of Medicinal Chemistry (2018) Vol. 62, Iss. 2, pp. 467-479
Open Access | Times Cited: 24

Showing 24 citing articles:

Urinary tract infections: microbial pathogenesis, host–pathogen interactions and new treatment strategies
Roger D. Klein, Scott J. Hultgren
Nature Reviews Microbiology (2020) Vol. 18, Iss. 4, pp. 211-226
Open Access | Times Cited: 420

Non-traditional Antibacterial Therapeutic Options and Challenges
Ursula Theuretzbacher, Laura J. V. Piddock
Cell Host & Microbe (2019) Vol. 26, Iss. 1, pp. 61-72
Open Access | Times Cited: 187

Antibiotics in the clinical pipeline as of December 2022
Mark S. Butler, Ian R. Henderson, Robert J. Capon, et al.
The Journal of Antibiotics (2023) Vol. 76, Iss. 8, pp. 431-473
Open Access | Times Cited: 136

Glycomimetics for the inhibition and modulation of lectins
Steffen Leusmann, Petra Ménová, Elena Shanina, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 11, pp. 3663-3740
Open Access | Times Cited: 59

A Review of Antibacterial Candidates with New Modes of Action
Mark S. Butler, Waldemar Vollmer, Emily C. A. Goodall, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 10, pp. 3440-3474
Open Access | Times Cited: 16

FimH and Anti-Adhesive Therapeutics: A Disarming Strategy Against Uropathogens
Meysam Sarshar, Payam Behzadi, Cecilia Ambrosi, et al.
Antibiotics (2020) Vol. 9, Iss. 7, pp. 397-397
Open Access | Times Cited: 100

Colibactin-driven colon cancer requires adhesin-mediated epithelial binding
Maude Jans, Magdalena Kolata, Gillian Blancke, et al.
Nature (2024) Vol. 635, Iss. 8038, pp. 472-480
Closed Access | Times Cited: 11

Lectin antagonists in infection, immunity, and inflammation
Joscha Meiers, Eike Siebs, Eva Zahorska, et al.
Current Opinion in Chemical Biology (2019) Vol. 53, pp. 51-67
Closed Access | Times Cited: 55

Isolation, synthesis and medicinal chemistry of biphenyl analogs – A review
Sandeep Singh, P Geetha, R. Ramajayam
Results in Chemistry (2023) Vol. 6, pp. 101135-101135
Open Access | Times Cited: 10

Small Carbohydrate Derivatives as Potent Antibiofilm Agents
Kartikey Singh, Suvarn S. Kulkarni
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 13, pp. 8525-8549
Closed Access | Times Cited: 15

Alternative treatment approaches of urinary tract infections caused by uropathogenic Escherichia coli strains
Beata Zalewska-Pia̧tek, Rafał Piątek
Acta Biochimica Polonica (2019)
Open Access | Times Cited: 25

Bacterial Anti-adhesives: Inhibition of Staphylococcus aureus Nasal Colonization
Allison C. Leonard, Laurenne E. Petrie, Georgina Cox
ACS Infectious Diseases (2019) Vol. 5, Iss. 10, pp. 1668-1681
Closed Access | Times Cited: 25

A Biomimetic Nonantibiotic Nanoplatform for Low‐Temperature Photothermal Treatment of Urinary Tract Infections Caused by Uropathogenic Escherichia coli
Wenjie Shi, Jinxia An, Tan He, et al.
Advanced Healthcare Materials (2021) Vol. 11, Iss. 3
Closed Access | Times Cited: 15

The photoredox-catalyzed hydrosulfamoylation of styrenes and its application in the novel synthesis of naratriptan
Mingjun Zhang, Miaomiao Chen, Xin Ding, et al.
Chemical Communications (2021) Vol. 57, Iss. 72, pp. 9140-9143
Closed Access | Times Cited: 13

Discovery of Orally Bioavailable FmlH Lectin Antagonists as Treatment for Urinary Tract Infections
Amarendar Reddy Maddirala, Kevin O. Tamadonfar, Jerome S. Pinkner, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 5, pp. 3668-3678
Closed Access | Times Cited: 1

Visible-Light-Induced Cascade Radical Cyclization to Access Sulfamoylated Benzo[4,5]imidazo[2,1-a]isoquinolin-6(5H)-ones
Rong Huang, Wenbo Wang, Kui Lu, et al.
Organic & Biomolecular Chemistry (2024)
Closed Access | Times Cited: 1

Novel approaches to glycomimetic design: development of small molecular weight lectin antagonists
Vishnu C. Damalanka, Amarendar Reddy Maddirala, James W. Janetka
Expert Opinion on Drug Discovery (2020) Vol. 16, Iss. 5, pp. 513-536
Closed Access | Times Cited: 10

Methods for O-Glycoside Synthesis
Károly Ágoston, Gregory M. Watt
Elsevier eBooks (2020), pp. 103-159
Closed Access | Times Cited: 5

Antibacterial agents reducing the risk of resistance development
Nailya А. Zigangirova, N. L. Lubenec, A.V. Zaitsev, et al.
Clinical Microbiology and Antimicrobial Chemotherapy (2021) Vol. 23, Iss. 2, pp. 184-194
Open Access | Times Cited: 5

The catheterized bladder environment promotes Efg1- and Als1-dependent Candida albicans infection
Alyssa Ann La Bella, Marissa J. Andersen, Nicholas C. Gervais, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 3

Elucidating novel antibacterial compounds from the NPASS database against the FimH lectin domain for the treatment of urinary tract infections: an in-silico study
Mrtatha K. Al-Zrkani, Rafid A. Abdulkareem, Dhurgham Al-Fahad, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 9, pp. 3914-3925
Closed Access | Times Cited: 2

Anti‐Infective Case Histories
Roland E. Dolle, Laurel K. McGrane, James W. Janetka, et al.
Burger's Medicinal Chemistry and Drug Discovery (2021), pp. 1-95
Closed Access

Page 1

Scroll to top